Search results

Jump to navigation Jump to search

Page title matches

Page text matches

  • ! Growth factor!! Chemotherapeutic agent !! Malignancy | [[Endothelial growth factor]]s || ||
    1 KB (171 words) - 09:06, 9 September 2020
  • ...ulates [[cell]] growth and [[differentiation]] by binding with [[epidermal growth factor]]s.
    162 bytes (19 words) - 11:56, 4 December 2010
  • #redirect [[Hepatocyte growth factor receptor]]
    47 bytes (5 words) - 00:19, 13 January 2009
  • #redirect [[Hepatocyte growth factor receptor]]
    47 bytes (5 words) - 01:07, 13 January 2009
  • #redirect [[Hepatocyte growth factor receptor]]
    47 bytes (5 words) - 01:07, 13 January 2009
  • #redirect [[Hepatocyte growth factor receptor]]
    47 bytes (5 words) - 01:08, 13 January 2009
  • {{r|Epidermal growth factor receptor||**}} {{r|Platelet-derived growth factor receptor||**}}
    2 KB (234 words) - 00:42, 13 January 2009
  • [[Cancer|Antineoplastic agent]] [[antibody]] that blocks [[epidermal growth factor]] (EGF) [[receptor]]s (EGFRs).
    149 bytes (16 words) - 11:35, 4 December 2010
  • ...sforming growth factor alpha]], amphiregulin, and heparin-binding EGF-like growth factor. The binding of ligand to the receptor causes activation of its intrinsic [
    1 KB (208 words) - 07:56, 1 May 2010
  • '''Hepatocyte growth factor receptor''' (HGFR) is a [[receptor tyrosine kinase]] that is essential for
    908 bytes (127 words) - 01:01, 13 January 2009
  • {{r|Insulin-like growth factor}} (IGF, also somatomedin)
    1 KB (175 words) - 08:13, 8 November 2010
  • ...aive lymphocytes. Other terms include Lymphocyte Mitogenic Factor, T-Cell Growth Factor, Thymocyte Stimulating Factor and T-Cell Stimulating Factor.<ref>{{MeSH}}</
    1 KB (158 words) - 01:09, 19 August 2010
  • ...y or Akt is an important downstream signaling component of tyrosine kinase growth factor and G-coupled receptors. Akt/PKB is activated by phosphorylation at two dis
    304 bytes (43 words) - 02:10, 16 May 2009
  • ...sive homology to and can heterodimerize with the EGF receptor ([[epidermal growth factor receptor]]), the [[erbB-3 receptor]] and the erbB-4 receptor. "<ref>{{MeSH} ...screening with v-ErbB (3) and has the highest homology to the [[epidermal growth factor receptor | EGFR]] among ErbB family members. It is mostly related to EGFR i
    2 KB (308 words) - 06:03, 16 July 2010
  • ...that blocks [[epidermal growth factor receptor|receptors]] for [[epidermal growth factor]]."<ref>{{MeSH}}</ref> ...s trial did not include patients whose cancers did not express [epidermal growth factor receptor]].
    3 KB (353 words) - 01:59, 23 September 2010
  • *[[IGF-1]] and other [[insulin-like growth factor]]s
    2 KB (286 words) - 02:03, 2 June 2009
  • {{r|Insulin-like growth factor}}
    2 KB (295 words) - 10:18, 30 May 2009
  • ...actor receptor|ErbB-1 receptor]], and [[ErbB-2 receptor]] (Human Epidermal growth factor Receptor 2, HER2, HER-2).
    2 KB (273 words) - 11:27, 4 May 2010
  • '''Bevacizumab''' is an "anti-VEGF (i.e., [[vascular endothelial growth factor A]]) <ref>{{citation | title = Vascular endothelial growth factor A isoform a [Homo sapiens]
    3 KB (376 words) - 14:53, 17 July 2010
  • ...ine]] rather than endocrine manner."<ref>{{MeSH}}</ref> Examples include [[growth factor]]s,[[interferon]]s, [[interleukin]]s, and [[tumor necrosis factor]].
    7 KB (926 words) - 17:47, 19 April 2010
  • *[[B-cell growth factor]] (BCGF)
    2 KB (346 words) - 00:56, 19 August 2010
  • ...pid]] metabolism. Many of the actions of GH are mediated by [[insulin-like growth factor-I]] (IGF-I) secreted from the liver in response to GH. GH secretion decline
    8 KB (1,288 words) - 00:04, 11 June 2010
  • ...causes hyperinsulinaemia and elevated serum levels of IGF-1 [insulin-like growth factor 1]. Both hormones are potent mitogens, stimulate growth, cell proliferation
    4 KB (600 words) - 17:05, 25 February 2013
  • {{r|Epidermal growth factor}} {{r|Panitumumab}}an "antibody that blocks receptors for epidermal growth factor (Entrez protein); approved for advanced colon cancer".[8]
    4 KB (467 words) - 00:17, 6 February 2009
  • ...mab]] chimeric recombinant monoclonal [[antibody]] that blocks [[epidermal growth factor receptor]] (EGFR).<ref name="pmid18784104">{{cite journal| author=Haddad RI
    3 KB (445 words) - 15:57, 28 June 2010
  • ...GPs) the function of which is at present unknown. Gas6 can function as a [[growth factor]] that activates the Axl [[receptor (biochemistry)|receptor]] [[tyrosine ki
    9 KB (1,333 words) - 07:35, 9 June 2009
  • ...high. The progression through G<sub>1</sub> may be affected by limiting [[growth factor]]s, nutrient supply, and additional inhibiting factors. A rapidly dividing
    5 KB (851 words) - 17:59, 13 January 2009
  • ...ce elaborated by another. This, of course, is the essential feature of all growth factor work and the basis of all studies of bacterial nutrition. However, this wor
    9 KB (1,423 words) - 16:37, 23 September 2013
  • ...ce elaborated by another. This, of course, is the essential feature of all growth factor work and the basis of all studies of bacterial nutrition. However, this wor
    9 KB (1,433 words) - 16:34, 23 September 2013
  • ...'' (2002) The rpf gene of Micrococcus luteus encodes an essential secreted growth factor ''Mol Microbiol'' 46: 611-21</ref><ref>Mukamolova GV ''et al.'' (1998) On r
    11 KB (1,679 words) - 06:09, 3 December 2010
  • ...mone]] (hGH), [[Insulin-like growth factor]]s ([[IGF-1]], etc.), [[Mechano growth factor]]s (MGFs), [[chorionic gonadatrophin]] (banned in men only), [[somatotrophi
    11 KB (1,234 words) - 07:26, 27 August 2013
  • ...mone]] (hGH), [[Insulin-like growth factor]]s ([[IGF-1]], etc.), [[Mechano growth factor]]s (MGFs), [[chorionic gonadatrophin]] (banned in men only), [[somatotrophi
    11 KB (1,231 words) - 15:55, 12 September 2019
  • ...e effects on membrane excitability ("neuromodulators"), others still are [[growth factor]]s. Some peptides influence [[synaptogenesis]], and glial cell morphology.
    8 KB (1,118 words) - 17:09, 21 March 2024
  • ...tin cells, and negative feedback from growth hormone and from insulin-like growth factor I (IGF-I), the production of which by the liver is stimulated by grwoth hor
    10 KB (1,468 words) - 09:47, 8 August 2011
  • ...t, human/mouse chimeric [[monoclonal antibody]] that binds to [[epidermal growth factor receptor]] (ErbB1, EGFR) and may treat head and neck cancers, [[colorectal * [[Panitumumab]] is an "antibody that blocks receptors for [[epidermal growth factor receptor]]; approved for advanced [[colorectal cancer|colon cancer]]".<ref
    10 KB (1,356 words) - 06:07, 5 April 2024
  • ...f reluctant to fund potentially impactful research such as human epidermal growth factor receptor 2 (HER-2 or [[erbB-2 receptor]])<ref name="urlGrant System Leads C
    4 KB (550 words) - 13:15, 3 February 2010
  • ...allows protection from apoptosis in conditions where there is a deficit in growth factor. The latent membrane protein 1 of EBV and CD40 its functional homologue ca
    5 KB (712 words) - 22:32, 14 February 2010
  • ...o E, Nuñez A, Busiguina S, Torres-Aleman I |title=Circulating insulin-like growth factor I mediates effects of exercise on the brain |journal=J. Neurosci. |volume=2
    8 KB (1,147 words) - 08:16, 4 April 2011
  • ...ame=Gilbert09>Gilbert J (2009) Behavioral effects of systemic transforming growth factor-alpha in Syrian hamsters ''Behav Brain Res'' 198:440-8</ref>
    12 KB (1,822 words) - 23:48, 25 October 2013
  • dilutions of epidermal growth factor (EGF) on </span><i><span style="font-size:7.5pt;font-family:Optima-BoldObli ...., Moubry K., Vallot N., Bastide M. "Effect of high dilutions of epidermal growth factor (EGF) on in vitro proliferation of keratinocyte and fibroblast cell lines"
    76 KB (9,749 words) - 23:07, 17 February 2009
  • ...d cells.<ref name=Chiaretti>Chiaretti, A., et al., Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traum ...context.<ref name=Chiaretti>Chiaretti, A., et al., Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traum
    24 KB (3,448 words) - 08:27, 19 March 2012
  • ...exercise]] in the case of [[muscle]]. For other tissues it needs various [[growth factor]]s to stimulate [[cell division]], or in some cases it needs [[stem cells]
    16 KB (2,439 words) - 14:29, 19 March 2023
  • ...d levels of [[tumor necrosis factor-alpha]] (TNF-alpha) and [[transforming growth factor]] beta (TGF-beta).<ref name="pmid17135584">{{cite journal| author=Belfort R
    13 KB (1,824 words) - 20:28, 25 June 2012
  • ...dipokines as mediators of [[inflammation]] and immune responses ''Cytokine Growth Factor Rev'' 18:313-25</ref><ref>Anderson PD ''et al.'' (2007) Innate immunity mod | '''[[Insulin-like growth factor-I]]&nbsp;'''
    31 KB (4,537 words) - 09:57, 18 February 2011
  • ...growth factor]] beta, [[fibroblast growth factor]] and [[platelet-derived growth factor]]. Synovial macrophages and dentritic cells function as antigen presenting
    38 KB (5,208 words) - 09:02, 1 March 2024
  • ...acellular matrix]]); (4) generation, storage and release of [[fat]]; (5) [[growth factor]] production; (6) [[glucose]] metabolism; (6) production of factors that af
    22 KB (3,243 words) - 08:33, 17 April 2024
  • |rowspan=2 |discovery of [[growth factor]]s
    21 KB (2,676 words) - 09:02, 1 March 2024
  • ...e|cultured]] skin cells, is also used to cover venous ulcers and excrete [[growth factor]]s to help them heal.<ref name="Mustoe2005">Mustoe T. 2005. [http://www.p
    14 KB (1,961 words) - 13:19, 23 February 2015
  • ...[bone marrow]] depends on stimulation of [[erythroid stem cells]] by the [[growth factor]], [[erythropoietin]]. [[Erythropoietin]] is principally manufactured in t
    24 KB (3,305 words) - 00:48, 22 December 2014
  • ...intermediate purification step to separate the correctly folded form of a growth factor, such as IGF-1, from a misfolded, yet stable form. HIC has also been shown
    17 KB (2,435 words) - 22:09, 18 December 2010
  • ...sk may be due to increased affinity of insulin analogues to [[insulin-like growth factor I]].<ref name="pmid10866053">{{cite journal| author=Kurtzhals P, Schäffer
    21 KB (2,988 words) - 06:24, 9 October 2013
  • # Abnormal [[growth factor]] signaling in the interaction between [[stromal cells]] and [[epithelial c ...eceptors for sex steroid hormones and cell surface receptors for epidermal growth factor receptor.
    101 KB (14,716 words) - 09:04, 5 April 2024
  • ...ercise]], in the case of [[muscle]]. For other tissues, it needs various [[growth factor]]s to stimulate [[cell division]]; in some cases it needs [[stem cells]].
    54 KB (8,078 words) - 09:18, 1 July 2023
  • Cetuximab, an I<sub>g</sub>G1 chimeric monoclonal antibody against epidermal growth factor receptor, may help according to a [[randomized controlled trial]].<ref name
    31 KB (4,194 words) - 13:28, 10 February 2023